Sankyo

Business

Merck inks $22B cancer drug deal with Daiichi Sankyo

Erik S. Lesser/Getty Images News Merck (NYSE:MRK) announced Thursday an agreement with Japanese pharma Daiichi Sankyo (OTCPK:DSKYF) to jointly develop…

Read More »
Back to top button